- Home
- FULC vs BHB Comparison
FULC vs BHB Comparison
Compare FULC & BHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- BHB
- Stock Information
- Founded
- FULC 2015
- BHB 1887
- Country
- FULC United States
- BHB United States
- Employees
- FULC N/A
- BHB N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- BHB Major Banks
- Sector
- FULC Health Care
- BHB Finance
- Exchange
- FULC Nasdaq
- BHB Nasdaq
- Market Cap
- FULC 468.1M
- BHB 481.0M
- IPO Year
- FULC 2019
- BHB 1997
- Fundamental
- Price
- FULC $11.74
- BHB $28.68
- Analyst Decision
- FULC Buy
- BHB Buy
- Analyst Count
- FULC 7
- BHB 2
- Target Price
- FULC $10.43
- BHB $34.50
- AVG Volume (30 Days)
- FULC 922.1K
- BHB 51.4K
- Earning Date
- FULC 10-29-2025
- BHB 10-21-2025
- Dividend Yield
- FULC N/A
- BHB 4.40%
- EPS Growth
- FULC N/A
- BHB N/A
- EPS
- FULC N/A
- BHB 2.31
- Revenue
- FULC N/A
- BHB $152,613,000.00
- Revenue This Year
- FULC N/A
- BHB $19.19
- Revenue Next Year
- FULC N/A
- BHB $12.86
- P/E Ratio
- FULC N/A
- BHB $12.61
- Revenue Growth
- FULC 2752.05
- BHB 3.15
- 52 Week Low
- FULC $2.32
- BHB $26.43
- 52 Week High
- FULC $12.14
- BHB $37.56
- Technical
- Relative Strength Index (RSI)
- FULC 72.74
- BHB 44.99
- Support Level
- FULC $7.51
- BHB $28.60
- Resistance Level
- FULC $9.05
- BHB $30.10
- Average True Range (ATR)
- FULC 0.80
- BHB 0.77
- MACD
- FULC 0.27
- BHB -0.02
- Stochastic Oscillator
- FULC 89.63
- BHB 32.92
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About BHB Bar Harbor Bankshares Inc.
Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..